BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 15093908)

  • 1. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Park I; Tamai G; Lee MC; Chuang CF; Chang SM; Berger MS; Nelson SJ; Pirzkall A
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):381-9. PubMed ID: 17513061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
    Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
    Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
    J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
    Oh J; Henry RG; Pirzkall A; Lu Y; Li X; Catalaa I; Chang S; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2004 May; 19(5):546-54. PubMed ID: 15112303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
    Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
    Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-spectroscopy guided target delineation for high-grade gliomas.
    Pirzkall A; McKnight TR; Graves EE; Carol MP; Sneed PK; Wara WW; Nelson SJ; Verhey LJ; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):915-28. PubMed ID: 11429219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.
    Kleinberg L; Yoon G; Weingart JD; Parisi M; Olivi A; Detorie NA; Chan TA
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1385-91. PubMed ID: 19394153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery.
    Senft C; Seifert V; Hermann E; Franz K; Gasser T
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):257-66; discussion 266-7. PubMed ID: 18981831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.
    Floeth FW; Wittsack HJ; Engelbrecht V; Weber F
    Zentralbl Neurochir; 2002; 63(1):23-8. PubMed ID: 12098080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
    Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.